Indeed, a Mendelian randomisation analysis of CHD that instruments CRP using a genome-wide approach gives contradictory answers, with some genetic predictors of increased CRP levels being associated with lower risk of CHD, and others being associated with higher risk of CHD. This evidence concerns the gene CRP and coronary artery disorder.